- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 150-38-9] Ethylenediaminetetraacetic acid trisodium salt
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-B1009 |
| Brand: | MCE |
| CAS: | 150-38-9 |
Overview
| MDL | MFCD00013305 |
|---|---|
| Molecular Weight | 358.19 |
| Molecular Formula | C10H13N2Na3O8 |
| SMILES | O=C(O)CN(CCN(CC(O[Na])=O)CC(O[Na])=O)CC(O[Na])=O |
5 Publications Citing Use of MCE
Summary
Ethylenediaminetetraacetic acid trisodium salt (EDTA trisodium salt) is used to bind metal ions in the practice of chelation therapy, for treating mercury and lead poisoning, used in a similar manner to remove excess iron from the body, for treating the complication of repeated blood transfusions, as would be applied to treat thalassaemia.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT04310254 | Istanbul Medipol University Hospital |
Postoperative Pain|Endodontically Treated Teeth
|
September 1, 2019 | Not Applicable |
| NCT04067245 | University Health Network, Toronto |
Catheter Complications
|
April 1, 2019 | Not Applicable |
| NCT05170932 | Ain Shams University |
Periodontal Bone Loss
|
January 2017 | Not Applicable |
| NCT04893577 | University of Utah |
Herpes Simplex Oral
|
January 20, 2022 | Phase 2 |
| NCT00044213 | Mt. Sinai Medical Center, Miami|National Heart, Lung, and Blood Institute (NHLBI)|National Center for Complementary and Integrative Health (NCCIH) |
Coronary Artery Disease
|
September 2003 | Phase 3 |
| NCT02714075 | Swiss Federal Institute of Technology|University for Development Studies, Tamale, Ghana |
Iron Deficiency and+or Anemia
|
April 2016 | Not Applicable |
| NCT03336970 | Mehmet Kemal �al??kan|Ege University |
Root Canal Infection
|
January 1, 2011 | Not Applicable |
| NCT04559334 | Boston Children´s Hospital|SterileCare Inc. |
Central Line Complication|Central Line-associated Bloodstream Infection (CLABSI)
|
December 21, 2020 | Not Applicable |
| NCT03419429 | Ain Shams University |
Chronic Periodontitis
|
January 2016 | Phase 4 |
| NCT02286258 | Assistance Publique - Hôpitaux de Paris|Ministry of Health, France |
Renal Insufficiency, Chronic|Kidney Diseases
|
October 2014 | Phase 1|Phase 2 |
| NCT01118663 | Cumberland Pharmaceuticals |
Acetaminophen Overdose
|
September 2010 | Phase 3 |
| NCT03424746 | Mt. Sinai Medical Center, Miami |
Critical Limb Ischemia|Peripheral Arterial Disease
|
August 2015 | Early Phase 1 |
| NCT03853200 | Dow University of Health Sciences |
Endodontic Disease|Root Canal Infection
|
April 3, 2017 | Phase 2|Phase 3 |
| NCT04044417 | Ain Shams University |
Periodontitis
|
August 25, 2016 | Phase 4 |
| NCT00227409 | Chang Gung Memorial Hospital |
Urologic Disease
|
November 2001 | Not Applicable |
| NCT00237952 | Chang Gung Memorial Hospital |
Diabetic Nephropathies|Diabetes Mellitus, Type II
|
August 2005 | Not Applicable |
| NCT04980066 | Kafrelsheikh University |
Gingival Recession
|
August 3, 2021 | Not Applicable |
| NCT02733185 | Mt. Sinai Medical Center, Miami|National Center for Complementary and Integrative Health (NCCIH)|National Heart, Lung, and Blood Institute (NHLBI)|Duke Clinical Research Institute |
Diabetes|Myocardial Infarction
|
October 2016 | Phase 3 |
| NCT04154553 | University Hospital, Basel, Switzerland|Toppharm Apotheke Hersberger, Spalenberg 41, CH-4051 Basel |
Adverse Drug Reaction|Therapy Failure
|
October 15, 2019 | |
| NCT05064462 | Assistance Publique - Hôpitaux de Paris|BioMérieux |
Heart Transplant Rejection|Heart Transplant Infection|Virus
|
March 3, 2022 | |
| NCT00757458 | University of Sao Paulo|AstraZeneca |
Drug Contamination
|
December 2008 | Not Applicable |
| NCT01950975 | Centre Hospitalier Universitaire Dijon |
Malformations With Skin Manifestations Suggesting Mosaicism
|
Not Applicable | |
| NCT03985371 | University of Rochester|Livionex Inc |
Corneal Dystrophy, Band-Shaped
|
June 29, 2020 | Early Phase 1 |
| NCT03253393 | The University of New South Wales|Menicon Co., Ltd. |
Optometry
|
June 4, 2018 | Not Applicable |
| NCT04786327 | Tanta University |
Periodontal Regeneration
|
January 1, 2018 | Phase 2 |
| NCT04548713 | Fraser Health|SterileCare Inc.|Center for Health Evaluation & Outcome Services |
Central Venous Catheter Thrombosis|Central Venous Catheter Related Bloodstream Infection|Catheter Complications|Catheter Blockage|Catheter Dysfunction|Central Line-associated Bloodstream Infection (CLABSI)|Catheter|Catheter Infection
|
March 22, 2022 | Not Applicable |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
H 2 O : 50 mg/mL ( 139.59 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.7918 mL | 13.9591 mL | 27.9181 mL |
| 5 mM | 0.5584 mL | 2.7918 mL | 5.5836 mL |
| 10 mM | 0.2792 mL | 1.3959 mL | 2.7918 mL |
-
1.
Add each solvent one by one: PBS
Solubility: 50 mg/mL (139.59 mM); Clear solution; Need ultrasonic
Synonyms
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.